Previous 10 | Next 10 |
Iveric Bio is developing Zimura - indicated for Geographic Atrophy - an eye disease that often leads to blindness. Zimura has met its primary endpoint in a pivotal Phase 3 trial, and data from a fully enrolled second Phase 3 will be available in H222. Zimura's chief rival Pegcetac...
Apple grabbed headlines Friday with a court ruling in its ongoing legal battle with Epic Games. While the decision weighed down AAPL shares, it had a more positive influence on a host of game developers. Zynga (NASDAQ:ZNGA), Activision (NASDAQ:ATVI) and Electronic Arts (NASDAQ:EA) all finishe...
IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will present an overview of the Company at the H.C. Wainwright 23 rd Annual Global Investment Conference, being held virtually from September 13-15, 2021. The on-demand presentation will b...
Gainers: IVERIC (NASDAQ:ISEE) +62%. Echo (NASDAQ:ECHO) +53%. Endo International plc (NASDAQ:ENDP) +35%. Affirm (NASDAQ:AFRM) +32%. Elite Education (NASDAQ:EEIQ) +30%. SigmaTron (NASDAQ:SGMA) +25%. Onion Global (NYSE:OG) +21%. Farmmi (NASDAQ:FAMI) +20%. Aterian (NASDAQ:ATER) +19%. Camber Energ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Camber Energy (NYSEAMERICAN: CEI ) stock is on the rise Friday as the short-squeeze target gets another boost from retail traders. Source: John Brueske/Shutterstock.com We’re looking at another case of ...
Iveric Bio (NASDAQ: ISEE) stock is blowing through the roof even though the company didn't have any news to share today. As of 11:07 a.m. EDT on Friday, shares of the clinical-stage biopharmaceutical company were up 56.8% thanks to lackluster results from a potential competitor. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Echo Global Logistics (NASDAQ: ECHO ) stock is getting a major boost on Friday thanks to a merger deal with The Jordan Company . Source: Shutterstock.com Funds managed by The Jordan Company will be used to t...
Gainers: IVERIC bio (NASDAQ:ISEE) +56%, Endo (NASDAQ:ENDP) +46%, NGM Biopharmaceuticals (NASDAQ:NGM) +16%, Arbutus Biopharma (NASDAQ:ABUS) +15%, CareMax (NASDAQ:CMAX) +11%. Losers: Apellis Pharmaceuticals (NASDAQ:APLS) -50%, Mersana Therapeuti...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips IVERIC bio (NASDAQ: ISEE ) stock is rocketing higher on Friday and there’s a couple of catalysts behind the shares’ positive movement today. Source: Shutterstock First off, we have to talk about ...
IVERIC bio (NASDAQ:ISEE) +65% Apellis' mixed eye-drug data turns out to be 'positive' for Iveric Bio Vince Holding (NYSE:VNCE) +22% on Q2 earnings. Affirm Holdings (NASDAQ:AFRM) +21% on Q4 earnings. Endo International (NASDAQ:ENDP) +18% settles New York state opi...
News, Short Squeeze, Breakout and More Instantly...
Astellas Completes Acquisition of Iveric Bio PR Newswire TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura , "Astellas") today announced that it has successfully completed the acquisit...
Shares of IVERIC bio, Inc. (NASDAQ: ISEE) traded at a new 52-week high today and are currently trading at $39.73. So far today, approximately 1.78M shares have been exchanged, as compared to an average 30-day volume of 5.04M shares. IVERIC bio, Inc., a biopharmaceutical company, discovers and...
IVERIC bio, Inc. (NASDAQ: ISEE) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 1.93% on the day to $38.77. IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal disease...